glp-1 and eye disease Medications NAION: What Patients Should Know About Sudden Vision Loss Semaglutide Tied to Increased Risk

This does not change the unit-to-mg conversion

Timestamped Show Notes [00:00:00] Introduction - Brittany's home office with plants and dogs [02:02] The "holistic" medicine debate [04:02] Why Brittany opened Sweetgrass Psychiatry [07:00] Bringing family medicine in-house [10:01] The economics of integrating primary care [11:08] Scaling to 30 clinicians [13:41] Full suite of interventional services offered [15:08] Nine out of twenty patients on GLP-1s [16:15] Depression and metabolic syndrome: 50/50 overlap [19:03] GLP-1s and the mesolimbic system [20:24] JAMA Psychiatry study on semaglutide for alcohol use disorder [21:17] Dr

Their joint consensus statement concluded that the existing literature indicates a possible small increased risk of NAION in patients taking semaglutide, but the risk remains low and is yet to be confirmed

As a result, there has been a rapid increase in GLP-1 vision loss lawsuits filed by patients who experienced sudden and permanent vision loss after using these drugs